Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Manjula Gunawardana(Oak Crest Institute of Science), Marc M. Baum(Oak Crest Institute of Science), Christina M. Ramirez(University of California, Los Angeles), Martin Béliveau, Simon G. Webster(Bangor University), Paul Webster(Unknown), Philippe Gallay(Scripps Research Institute), Rob Fanter(Oak Crest Institute of Science), Mariana Remedios-Chan(Oak Crest Institute of Science), Mark A. Marzinke(Family Health International 360), Debbie Sanchez(Oak Crest Institute of Science), John A. Moss, Joseph Kuo(Scripps Research Institute), MyMy Trinh
Cited by 6
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483